Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12 EUR | +0.84% | +3.45% | -3.23% |
05-14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
05-09 | Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up | MT |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG2024-05-15 | 2024-05-16 | 2024-05-17 | 2024-05-20 | |
---|---|---|---|---|
Last | 11.5 € | 11.8 € | 11.9 € | 12 € |
Change | 0.00% | +2.61% | +0.85% | +0.84% |
Performance
1 day | +0.84% | ||
1 week | +3.45% | ||
Current month | +9.09% | ||
1 month | +34.83% | ||
3 months | +15.38% | ||
6 months | -10.45% | ||
Current year | -3.23% | ||
1 year | -24.53% | ||
3 years | -40.94% | ||
5 years | +31.32% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+0.84% | +3.45% | -3.23% | -24.53% | 18.08B | ||
+0.15% | +3.71% | +9.58% | +30.49% | 115B | ||
+0.51% | +1.06% | +12.41% | +30.07% | 106B | ||
-1.56% | -3.82% | -2.59% | -13.36% | 21.96B | ||
+2.05% | -0.27% | -12.38% | -13.17% | 21.87B | ||
+0.74% | +1.90% | -5.29% | -27.68% | 19.21B | ||
-0.45% | -0.33% | -38.57% | -33.48% | 17.71B | ||
-0.45% | +4.04% | +7.51% | +50.60% | 14.32B | ||
-0.42% | -0.66% | +35.67% | -12.25% | 12.42B | ||
+0.60% | +5.72% | -24.50% | -34.85% | 8.23B | ||
+1.82% | +15.57% | +20.91% | +57.43% | 8.11B | ||
-0.12% | -0.02% | -0.83% | +29.54% | 7.67B | ||
-0.14% | -4.23% | -52.57% | -66.69% | 7.49B | ||
+0.77% | -6.68% | +262.79% | +193.93% | 7.39B | ||
-0.04% | -8.29% | -3.87% | +33.94% | 6.95B | ||
+1.80% | +4.68% | -27.42% | +55.46% | 6.24B | ||
Average | +0.38% | -0.31% | +11.10% | +15.97% | ||
Weighted average by Cap. | +0.32% | +1.55% | +7.80% | +17.65% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -3.23% | ||
2023 | -21.59% | ||
2022 | -7.84% | ||
2021 | +11.43% | ||
2020 | +35.09% | ||
2019 | +25.69% | ||
2018 | -17.92% |
- Stock Market
- Equities
- BGNE Stock
- 49B Stock
- Quotes BeiGene, Ltd.